# Mustn1 ablation in male mice results in fiber type and gene expression alterations during skeletal muscle regeneration

**Authors:** Kaitlin Tagliaferri, Nithya Thomas, Michael Atallah, Stavroula Triantafillou, Michael Hadjiargyrou

PMC · DOI: 10.14814/phy2.70772 · Physiological Reports · 2026-02-19

## TL;DR

Removing Mustn1 in male mice changes muscle fiber types and gene activity during muscle repair.

## Contribution

The study reveals Mustn1's role in altering muscle fiber composition and gene expression during regeneration.

## Key findings

- Mustn1 KO mice showed increased Type IIa fibers and decreased Type IIx and IIb fibers during regeneration.
- Mustn1 KO mice had larger Type I fiber cross-sectional area and fewer centrally nucleated fibers at Day 10.
- Pax7+ cell numbers and myogenic gene expression were altered in Mustn1 KO mice.

## Abstract

We previously developed a Mustn1 conditional knockout (KO) mouse model targeting Pax7‐expressing skeletal muscle satellite cells and showed its role in glucose metabolism, strength, gait, peak contractile strength, and myofiber composition. To investigate Mustn1's role in muscle regeneration, we used these KO mice in a cardiotoxin (CTX)‐induced tibialis anterior injury model. Despite no major histological differences or deficits in ladder climbing between KO and wild‐type (WT) mice at post‐injury (Day 2–10), we observed significant shifts in fiber type composition. Mustn1 KO mice had more Type IIa fibers at Day 5, while Type IIx and IIb fibers were reduced at Day 2 and 10, respectively. Additionally, we observed increases in Type I fiber cross‐sectional area in the Mustn1 KO mice at Day 0 and 2. Lower numbers of centrally nucleated fibers were also seen in the Mustn1 KO mice at Day 10. Pax7+ cells were also greater in numbers in the Mustn1 KO mice at Day 2 and 10. Lastly, expression of myogenic genes also differed significantly between the two strains. These data suggest that Mustn1 is integral to skeletal muscle fiber composition and myogenic gene expression thereby facilitating muscle repair and regeneration.

## Linked entities

- **Genes:** MUSTN1 (musculoskeletal, embryonic nuclear protein 1) [NCBI Gene 389125], PAX7 (paired box 7) [NCBI Gene 5081]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Myog (myogenin) [NCBI Gene 17928] {aka MYF4, bHLHc3, myo}, Cap1 (cyclase associated actin cytoskeleton regulatory protein 1) [NCBI Gene 12331], Myod1 (myogenic differentiation 1) [NCBI Gene 17927] {aka MYF3, MyoD, Myod-1, bHLHc1}, Myf5 (myogenic factor 5) [NCBI Gene 17877] {aka B130010J22Rik, Myf-5, bHLHc2}, Des (desmin) [NCBI Gene 13346], Smpx (small muscle protein, X-linked) [NCBI Gene 66106] {aka 1010001C09Rik, Csl}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Myh4 (myosin, heavy polypeptide 4, skeletal muscle) [NCBI Gene 17884] {aka MHC2B, MM, MYH-2B, Minimsc, Minmus, MyHC-IIb}, Cdk2 (cyclin dependent kinase 2) [NCBI Gene 12566] {aka A630093N05Rik}, Hpd (4-hydroxyphenylpyruvic acid dioxygenase) [NCBI Gene 15445] {aka 4HPPD, Fla, Flp, Hppd, Laf}, Myh2 (myosin, heavy polypeptide 2, skeletal muscle, adult) [NCBI Gene 17882] {aka MHC2A, MyHC-2a, MyHC-IIa, Myh2a, Myhs-f, Myhs-f1}, PAX7 (paired box 7) [NCBI Gene 5081] {aka CMYO19, CMYP19, HUP1, MYOSCO, PAX7B, RMS2}, Myhc (myosin heavy chain, cardiac muscle complex) [NCBI Gene 111671], Pax7 (paired box 7) [NCBI Gene 18509] {aka Pax-7}, Mustn1 (musculoskeletal, embryonic nuclear protein 1) [NCBI Gene 66175] {aka 1110028G01Rik, Mustang}, Atp9a (ATPase, class II, type 9A) [NCBI Gene 11981] {aka IIa}, Mef2c (myocyte enhancer factor 2C) [NCBI Gene 17260] {aka 5430401D19Rik, 9930028G15Rik, Mef2}, Cav3 (caveolin 3) [NCBI Gene 12391] {aka Cav-3, M-cav}
- **Diseases:** TA (MESH:D037081), skeletal muscle disorders (MESH:D005207), GRMD (MESH:D009136), DMD (MESH:D020388), muscle disorders (MESH:D009135), fatigue (MESH:D005221), muscle degeneration (MESH:D009410), myogenic impairment (MESH:D060825), hypertrophy (MESH:D006984), fracture (MESH:D050723), muscle (MESH:D019042), sarcopenia (MESH:D055948), Skeletal injury (MESH:D014947)
- **Chemicals:** DAPI (MESH:C007293), formalin (MESH:D005557), glucose (MESH:D005947), PBS (MESH:D007854), eosin (MESH:D004801), oxandrolone (MESH:D010074), alcohol (MESH:D000438), isoflurane (MESH:D007530), TRIzol (MESH:C411644), water (MESH:D014867), Triton X-100 (MESH:D017830), nitrogen (MESH:D009584), hematoxylin (MESH:D006416), OCT (MESH:C051883), Triantafillou (-), H &amp; E (MESH:D006371)
- **Species:** Gallus gallus (bantam, species) [taxon 9031], Canis lupus familiaris (dog, subspecies) [taxon 9615], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** A 29G

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917859/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917859/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917859/full.md

---
Source: https://tomesphere.com/paper/PMC12917859